Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc. Website Screenshot


Xenon Pharmaceuticals Inc. Company Intro

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline include XEN496, A Kv7 potassium channel modulator that is Phase II clinical trials for the treatment of KCNQ2 epilepsy; XEN1101, A Kv7 potassium channel modulator, which is in Phase II clinical trial for the treatment of epilepsy. The company's product candidates also comprise XEN901, a selective Nav1.6 sodium channel inhibitor that is in Phase I clinical trials for the treatment of epilepsy; and XEN007, A central nervous system-acting calcium channel modulator, which is in Phase I clinical trials. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. to develop first-in-class treatments for epilepsy. The company was founded in 1996 and is headquartered in Burnaby, Canada.



Xenon Pharmaceuticals Inc. Headquaters

200 - 3650 Gilmore Way
Burnaby,V5G 4W8

Xenon Pharmaceuticals Inc. Share price

17 May 2023 14:08 GMT


0.0 (0.0 %)

Xenon Pharmaceuticals Inc. Market cap

$2.586 B



Xenon Pharmaceuticals Inc. # 218


Latest Xenon Pharmaceuticals Inc. News

News 30 Nov 2023

Xenon Pharmaceuticals Jumps 5% After Pricing $300 Mln ...

Shares of Xenon Pharmaceuticals Inc. (XENE) jumped over 5% on Thursday morning after pricing of $300 million offering. XENE is currently trading at $35.60,...

News 30 Nov 2023

Will Xenon Pharmaceuticals Inc (XENE) Stay at the Top of the ...

Xenon Pharmaceuticals Inc gets a 71 rank in the Healthcare sector. Healthcare is number 5 out of 11 sectors. Overall Score - 55. XENE has an Overall Score of 55...

News 30 Nov 2023

Form 8-K Xenon Pharmaceuticals For: Nov 29

XENON PHARMACEUTICALS INC. (Exact name of Registrant as Specified in Its Charter). Canada. 001-36687. 98-0661854. (State or Other Jurisdiction. of Incorporation).

WMC Market Score

WMC Market to Revenue Score

Xenon Pharmaceuticals Inc. Market Financials

Revenue, Expenses, Profit

Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Xenon Pharmaceuticals Inc. USD $29,446 $68,773 $-36,092 $25,860B 218
Regeneron Pharmaceuticals, Inc. USD $9,197,600 $3,997,800 $4,003,800 $804,390B 1
Vertex Pharmaceuticals Incorporated USD $6,414,881 $2,617,257 $2,762,032 $878,880B 2
Alexion Pharmaceuticals, Inc. USD $6,261,601 $2,747,200 $681,800 $ 3
Incyte Corporation USD $2,702,913 $2,048,306 $478,480 $144,340B 4

Market Analytics

Company Search vs Top 4 Industry Competitors

Total Xenon Pharmaceuticals Inc. Social Followers vs Top 4 Industry Competitors

Xenon Pharmaceuticals Inc. Post vs Top 4 Industry Competitors

Xenon Pharmaceuticals Inc. Digital Footprint By Size vs Top 4 Industry Competitors

Xenon Pharmaceuticals Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors

Xenon Pharmaceuticals Inc. WMC Market Score Calculations

Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Xenon Pharmaceuticals Inc. 0.32 0 0 0 0 0 0
Regeneron Pharmaceuticals, Inc. 100 25.50 16.15 28 0 0 29.94
Vertex Pharmaceuticals Incorporated 69.75 35.68 8.95 40 0 0 36.32
Alexion Pharmaceuticals, Inc. 68.08 100 100 32 0 0 100
Incyte Corporation 29.39 5.03 0.04 100 0 0 45.31

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb